Protalix BioTherapeutics
PLX
#8648
Rank
S$0.10 B
Marketcap
$1.43
Share price
-4.35%
Change (1 day)
-38.70%
Change (1 year)

Protalix BioTherapeutics (PLX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$82 M

According to Protalix BioTherapeutics 's latest financial reports the company's total liabilities are S$82 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Protalix BioTherapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$67.17 M-24.56%
2022-12-31S$89.05 M-17.15%
2021-12-31S$0.10 B-14.39%
2020-12-31S$0.12 B-19.31%
2019-12-31S$0.15 B0.19%
2018-12-31S$0.15 B14.21%
2017-12-31S$0.13 B1.9%
2016-12-31S$0.13 B9.12%
2015-12-31S$0.12 B-30.9%
2014-12-31S$0.17 B-0.43%
2013-12-31S$0.17 B76.97%
2012-12-31S$0.10 B-0.41%
2011-12-31S$0.10 B2.91%
2010-12-31S$98 M-15.76%
2009-12-31S$0.11 B1151.63%
2008-12-31S$9.29 M44.4%
2007-12-31S$6.43 M55.25%
2006-12-31S$4.14 M120.38%
2005-12-31S$1.88 M1697.1%
2004-12-31S$0.1 M-21.96%
2003-12-31S$0.13 M-2.22%
2002-12-31S$0.13 M-4.09%
2001-12-31S$0.14 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$0.80 B 879.94%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.03 B 1,164.00%๐Ÿ‡บ๐Ÿ‡ธ USA
S$167.00 B 203,553.17%๐Ÿ‡บ๐Ÿ‡ธ USA
S$45.29 B 55,134.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel